Skip to main content
Home / Current Medicinal Chemistry, Volume 18, Number 4

Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer

Buy Article:

$68.00 + tax (Refund Policy)

Authors: Portella, G.; Passaro, C.; Chieffi, P.

Source: Current Medicinal Chemistry, Volume 18, Number 4, 2011, pp. 482-496(15)

Publisher: Bentham Science Publishers

DOI: https://doi.org/10.2174/092986711794480203

Aurora B is a serine-threonine kinase belonging to the highly conserved Aurora family of mitotic kinases. Aurora B is a chromosomal passenger protein involved in chromosome segregation, spindle-checkpoint, and cytokinesis. Alteration of each of these steps could induce aneuploidy, one of main features, and driving force of cancer progression. The overexpression of Aurora B has been observed in several tumor types, and has been linked with a poor prognosis of cancer patients. In this review we will focus on the role of Aurora B in cancer development, its role as a prognostic marker, and the clinical outcome of recently developed Aurora(s) inhibitors.





Keywords: Aurora B; Aurora Inhibitors; Aurora kinase; Benzimidazoles; C. elegans; Cromosomal Passenger Complex; Cytokinesis Kinase; Drosophila; HESPERADIN; Histone Kinase; INner CENtromere Pro-tein (INCENP); Mi-totic Centromere-Associated Kinesin; Prognostic Marker; S. pombe; Saccharomyces cerevisiae; Spindle Checkpoint Kinase; Survivin; Testis Zinc Finger Protein (Tzfp); Tetrahymena thermophila; Therapeutic Target; Xenopus; acute lymphocytic leukemia; anaphase-promoting complex; aneuploidy; cancer; carcinoma; centrosome; chromosome; chronic mye-loid leukemia (CML); colon; cytokinesis; glioblastoma; hepatocellular carcinoma; indolinone; inhibitors; kinetochores; malignant en-dometrium; mesothelioma; microtubule-depolymerizing kinesin MCAK; mitosis; neoplastic lesions; oral cancer; phosphorylation; prometaphase; prostate; serine-threonine kinase; testicular germ; thyroid

Document Type: Research Article

Publication date: 01 February 2011

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content